| COVID-19 Vaccine |
1 |
1 |
| COVID-19 |
0 |
0.87 |
| Biologic Therapy |
0 |
0.75 |
| Vaccines |
0 |
0.74 |
| T-Lymphocyte |
0 |
0.65 |
| Severe Acute Respiratory Syndrome |
0 |
0.46 |
| CAR-T |
0 |
0.44 |
| Cancer |
0 |
0.33 |
| Immunization |
0 |
0.33 |
| Acute Respiratory Distress Syndrome |
0 |
0.32 |
| Antineoplastic Drug |
0 |
0.29 |
| Blood |
0 |
0.26 |
| Concerns of Elderly |
0 |
0.13 |
| Geriatrics |
0 |
0.13 |
| Hospital |
0 |
0.13 |
| Antigens |
0 |
0.07 |
| Arthritis |
0 |
0.07 |
| Autoimmune Disease |
0 |
0.07 |
| Clinical Research |
0 |
0.07 |
| Diversity |
0 |
0.07 |
| Immunocompromise |
0 |
0.07 |
| Immunology |
0 |
0.07 |
| Leukemia |
0 |
0.07 |
| Lymphoma |
0 |
0.07 |
| Monoclonal Antibody |
0 |
0.07 |
| Receptors |
0 |
0.07 |
| Rheumatoid Arthritis |
0 |
0.07 |
| Transplantation |
0 |
0.07 |
| Multiple Sclerosis |
0 |
0.05 |
| Social Determinants of Health |
0 |
0.05 |